08/10/2025
Nerandomilast, an oral PDE4B inhibitor from Boehringer Ingelheim, earns FDA approval as the first new IPF treatment in a decade.
MD MSc FCCP EDRM
Consultant in Respiratory Medicine
Fellowship in Interstitial Lung Disease
26 Pindarou Street (Alitheia Building)
1060
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 |
| Friday | 09:00 - 17:00 |
Be the first to know and let us send you an email when Dr Alexis Papadopoulos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Dr Alexis Papadopoulos:
Want your practice to be the top-listed Clinic?